Clinical Trial Update: Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

View source ↗

Summary

This prospective study evaluates high-resolution dual-energy CT imaging, noninvasive liquid biopsies, and minimally invasive surveillance for early detection of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bap1 Tumor Predisposition Syndrome
• Mesothelioma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Familial Cancer, BRCA1-Associated Protein-1 (BAP1) Mutations | Status: RECRUITING